Literature DB >> 10965150

Antisense studies in PC12 cells suggest a role for H218, a sphingosine 1-phosphate receptor, in growth-factor-induced cell-cell interaction and neurite outgrowth.

A J MacLennan1, B K Devlin, L Marks, A A Gaskin, K L Neitzel, N Lee.   

Abstract

Our previous studies of H218, a sphingosine 1-phosphate (S1P) receptor and a member of the G-protein-coupled receptor superfamily, suggest that it may participate in mammalian nervous system development. Thus, brain levels of H218 mRNA are higher during early neurogenesis than postnatally. In addition, embryonic H218 immunoreactivity is preferentially localized in young neuronal cell bodies during their early stages of differentiation and in axons during their extension. This report describes the morphological effects of reducing native H218 levels in PC12 cells. Western blot analyses demonstrated that PC12 cells stably transfected with an expression vector carrying an antisense-oriented H218 cDNA contain less H218 protein than vector-transfected control cells. When differentiated with growth factors, the antisense-H218 cells display more neurite production and form less cell-cell contacts than the control cells. Therefore, these data, along with our previous H218 expression studies and a recent, independent study of H218 overexpression, support the possibility that H218 contributes to developmental processes regulating neuronal interaction and axon growth. The data are also consistent with reports that H218 is a S1P receptor, that S1P is present in serum, like that used in our PC12 cell cultures, and that it causes PC12 cell neurite retraction. Finally, and in agreement with a S1P receptor role for H218, we find that the antisense-H218 cells display less S1P-induced neurite retraction than control cells. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965150     DOI: 10.1159/000017452

Source DB:  PubMed          Journal:  Dev Neurosci        ISSN: 0378-5866            Impact factor:   2.984


  10 in total

1.  Degenerate suppression PCR identifies the beta2-adrenergic receptor as upregulated by neuronal differentiation.

Authors:  Jan Lewerenz; Frank Leypoldt; Axel Methner
Journal:  Gene Expr       Date:  2003

2.  Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells.

Authors:  Paola Giussani; Anita Ferraretto; Claudia Gravaghi; Rosaria Bassi; Guido Tettamanti; Laura Riboni; Paola Viani
Journal:  Neurochem Res       Date:  2006-12-07       Impact factor: 3.996

3.  G-protein-coupled receptor cell signaling pathways mediating embryonic chick retinal growth cone collapse induced by lysophosphatidic acid and sphingosine-1-phosphate.

Authors:  Jarod Fincher; Canaan Whiteneck; Eric Birgbauer
Journal:  Dev Neurosci       Date:  2014-08-19       Impact factor: 2.984

Review 4.  Lysophospholipid receptors in the nervous system.

Authors:  Rachelle E Toman; Sarah Spiegel
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 5.  Lysophospholipids and their receptors in the central nervous system.

Authors:  Ji Woong Choi; Jerold Chun
Journal:  Biochim Biophys Acta       Date:  2012-07-31

Review 6.  The Role of Astrocytes in Multiple Sclerosis.

Authors:  Gerald Ponath; Calvin Park; David Pitt
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

Review 7.  The emerging role of FTY720 as a sphingosine 1-phosphate analog for the treatment of ischemic stroke: The cellular and molecular mechanisms.

Authors:  Maryam Naseh; Jafar Vatanparast; Ali Rafati; Mahnaz Bayat; Masoud Haghani
Journal:  Brain Behav       Date:  2021-05-10       Impact factor: 2.708

8.  Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension.

Authors:  Rachelle E Toman; Shawn G Payne; Kenneth R Watterson; Michael Maceyka; Norman H Lee; Sheldon Milstien; John W Bigbee; Sarah Spiegel
Journal:  J Cell Biol       Date:  2004-08-02       Impact factor: 10.539

Review 9.  Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks.

Authors:  Kira V Blankenbach; Stephanie Schwalm; Josef Pfeilschifter; Dagmar Meyer Zu Heringdorf
Journal:  Front Pharmacol       Date:  2016-06-21       Impact factor: 5.810

Review 10.  Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds.

Authors:  Seyed Khosrow Tayebati
Journal:  Molecules       Date:  2018-09-05       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.